Find and Pitch Jounalists, Get Your Story Covered

Tags: Alzheimer's disease | Alzheimer’s | biotech | biotechnology | Cancer | drug development | Drug prices | drug pricing | finance | Pharmaceuticals | research | Vaccines biotech pharma Research & Development research-development

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	10 of our most read articles in 2023 - 5 months ago The FDA just approved the first CRISPR drug. Here’s what’s next in gene editing. - 5 months ago PharmaVoice 100s: Entrepreneurs - 6 months ago PharmaVoice 100s: Clinical trial gurus - 7 months ago 3 recent FDA adcomm rejections — and why they matter - 8 months ago
2	Michael Gibney Pharma Voice	Biopharma’s FTC headache deepens with guideline shifts years in the making - 5 months ago Real Chemistry’s CEO on biopharma’s outlook in 2024 - 5 months ago A biotech tackles drug discovery with transcription factor know-how - 6 months ago The thorniest questions facing pharma, according to a leading bioethicist - 6 months ago How Big Pharma keeps the oncology engines hot with a host of strategies - 6 months ago The PharmaVoice 100: Rare disease warriors - 7 months ago FDA’s ‘ivory tower thinking’ ignores promising biomarkers, says a rare disease CEO - 7 months ago
3	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	What are pharma’s next blockbusters? - 5 months ago Oncology drugmakers seek the sweet spot between efficacy and tolerability - 5 months ago The weight loss market looks unstoppable. How high could it go? - 5 months ago Patient groups have become a powerhouse in R&D. Here’s a look at their impact. - 7 months ago Has the science of anti-aging caught up with the dream of a longer life? - 7 months ago
4	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	STAT+: 3 trends to watch in biotech in 2024 - 5 months ago Eli Lilly tries a rare tactic: competing on price - 6 months ago Cell and gene therapies could be a safer bet than other drugs - 7 months ago
5	Alexandra Pecci Pharma Voice Leading community for life sciences leaders. Washington, D.C. pharmaceuticalslife sciencescommunity building	5 noteworthy pharma AI investments in 2023 - 5 months ago Biopharma’s top 5 IPOs of 2023 (so far) - 6 months ago 5 of the best paid biopharma CEOs - 6 months ago In a record year for biotech bankruptcy, here are 3 companies that went under - 6 months ago To close the pediatric innovation gap, this biotech has to think differently - 7 months ago Where have all the unicorns gone? A look at 4 billion-dollar biotechs - 7 months ago
6	Neal Masia Pharmaceutical Executive	The Price of Prescriptions: Getting it Right - 5 months ago
7	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 5 months ago FDA chastens pet companies over antibiotics - 5 months ago Novartis is building a new radioligand plant in China - 5 months ago Want a biotech buyout? Target cancer - 7 months ago NIH funds expanded access projects for ALS - 7 months ago
8	Seema Verma Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
9	SVP and GM Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
10	Oracle Life Sciences Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago

Journalists covering biotech | biotechnology | Cancer | Congress | drug development | Drug prices | drug pricing | FDA | finance | Pharmaceuticals | research